Bonnet J, Thibaudeau D, Bessin P
Prostaglandins. 1983 Sep;26(3):457-66. doi: 10.1016/0090-6980(83)90180-6.
The Paf-acether (platelet-activating factor) induced bronchospasm (Paf-BCS) was studied in the anesthetized guinea-pig. The SRS antagonist, FPL-55712, as well as inhibitors of both lipoxygenase and cyclooxygenase, phenidone, nordihydroguaiaretic acid (NDGA), and benoxaprofen, caused a dose-related antagonism of Paf-BCS. By contrast, selective inhibitors of cyclooxygenase, indomethacin and aspirin, exerted moderate antagonism at intermediate doses, but had no effect at high doses. Furthermore, diethylmaleate (DEM), which impairs leukotriene synthesis by interfering with glutathione (GSH), suppressed Paf-BCS. Taken together, these results demonstrate that the lipoxygenase pathway plays a major part in the bronchospasmogenic effect of Paf-acether in the guinea-pig.
在麻醉的豚鼠中研究了血小板活化因子(Paf - 乙酰醚)诱导的支气管痉挛(Paf - BCS)。SRS拮抗剂FPL - 55712以及脂氧合酶和环氧化酶的抑制剂非那吡啶、去甲二氢愈创木酸(NDGA)和苯恶洛芬,均引起了与剂量相关的Paf - BCS拮抗作用。相比之下,环氧化酶的选择性抑制剂吲哚美辛和阿司匹林在中等剂量时发挥中等程度的拮抗作用,但在高剂量时无效。此外,通过干扰谷胱甘肽(GSH)损害白三烯合成的马来酸二乙酯(DEM)抑制了Paf - BCS。综上所述,这些结果表明脂氧合酶途径在豚鼠中Paf - 乙酰醚的支气管痉挛ogenic作用中起主要作用。